Vydura 75mg Tablets

Description

Vydura 75mg Tablets contain rimegepant, a CGRP receptor antagonist used for the acute treatment of migraine attacks, with or without aura, in adults. This innovative migraine treatment provides fast relief by targeting the calcitonin gene-related peptide (CGRP) pathway, a key contributor to migraine symptoms.

Vydura is taken as-needed and is not intended for daily use or for migraine prevention. The tablet is orally disintegrating, meaning it dissolves under the tongue without the need for water—ideal for rapid relief when migraine symptoms begin.

Key Benefits:

• Contains rimegepant 75mg – a CGRP receptor antagonist

• Provides fast relief from acute migraine attacks

• Orally disintegrating tablet – no water needed

• Effective for migraines with or without aura

• Suitable for adults aged 18+

Active Ingredient:
Rimegepant 75mg

Pack Size:
Available in single-dose or multi-dose packs (commonly 2, 4, or 8 tablets)

Directions for Use:
Place one tablet under the tongue and allow it to dissolve completely. Do not chew or swallow whole. Take at the onset of migraine symptoms. Do not take more than one tablet in 24 hours. Maximum of 18 doses per month.

Warnings:
Prescription only. Not for use in patients with severe liver or kidney disease. Do not use with other CGRP inhibitors. Not intended for migraine prevention. Always follow your doctor’s instructions and read the patient information leaflet before use.